Fifth Third Bancorp’s KALA BIO KALA Stock Holding History

Fifth Third Bancorp’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1	Closed	-$5K	–	2278
2019 Q3	$5K	Buy	+1	New	+$12.2K	﹤0.01%	1927

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBVA

Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fifth Third Bancorp's KALA Position: Q4 2019 in Review

Fifth Third Bancorp sold out of KALA BIO (KALA) in Q4 2019, closing a stake of 1 share — an estimated $5K sold.

Fifth Third Bancorp first reported a position in KALA in Q3 2019 and held it in 1 quarter. The position peaked at $5K in Q3 2019. 63 funds tracked by Wall St. Rank hold KALA as of Q4 2019.

Fifth Third Bancorp reported no remaining KALA BIO position as of Q4 2019 after selling out during the quarter.
Fifth Third Bancorp sold 1 KALA BIO share in Q4 2019, an estimated $5K.
Fifth Third Bancorp first reported a position in KALA BIO in Q3 2019 and held it in 1 quarter.
Fifth Third Bancorp's KALA BIO position peaked at $5K in Q3 2019.
63 funds tracked by Wall St. Rank held KALA BIO as of Q4 2019.

Based on Fifth Third Bancorp's 13F filing for Q4 2019, filed 14 Feb 2020.